Search Results 621-630 of 19194 for Hemoglobin

  1. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

    ... hemoglobin (HGB) <10 g/dL at any dose and any duration of HU, or Presence of HU-related toxicities at any dose and any duration of therapy (e.g., leg ulcers ...

  2. The Use of the Cerebral Oximetry for Patients Undergoing Dynamic Computed Tomography Myelography under General Anesthesia - Mayo Clinic

    Systemic hemodynamic data (ie, heart rate, systemic blood pressure, peripheral hemoglobin oxygen saturation); Cerebral oximetric data recorded at 2 minute ...

  3. A Study of Bezisterim (NE3107) in Adults with Long COVID - Mayo Clinic

    Hemoglobin ≤ 10 g/dL if female, ≤11.5 g/dL if male; International normalized ratio (INR) > 1.5 if not on anticoagulant medication; if the participant is on ...

  4. Myelofibrosis - Diagnosis and treatment - Mayo Clinic

    Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.

  5. A Study of 9-ING-41 in Patients with Advanced Cancers - Mayo Clinic

    hemoglobin ≥ 8.5 g/dL, platelets ≥ 50,000/mL 2. Adequate liver function: transaminases (aspartate aminotransferase/ alanine aminotransferase, AST/ALT) and ...

  6. Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer - Mayo Clinic

    Hemoglobin > 9.0 g/dL; Total serum bilirubin ≤ 2 mg/dL; Aspartate transaminase (AST) ≤ 2.5 x upper limit of normal (ULN) (≤ 5 x ULN in patients with liver ...

  7. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Adequate hematology laboratory results (absolute neutrophil count ≥ 1.5 x 10^9/L, platelet count ≥ 75 x 10^9/L, hemoglobin ≥ 10.0 g/dL). Adequate ...

  8. Aortic Valve Repair And Aortic Valve Replacement Clinical Trials - Mayo Clinic Research

    The purpose of this study is to test if a reduction of hemoglobin leads to subclinical cardiac dysfunction in patients with known cardiovascular disease. .

  9. A Study to Evaluate Injectafer® as Treatment for Heart Failure with Iron Deficiency - Mayo Clinic

    Hemoglobin > 9.0 g/dL and < 13.5 g/dL (females) or < 15.0 g/dL (males) within 28 days of randomization. Serum ferritin < 100 ng/mL or 100 to 300 ng/mL with ...

  10. Home Care Treatment With Oral Chemotherapy For Recurrent Or Metastatic Oral Cavity Cancer - Mayo Clinic

    Hemoglobin ≥9.0 g/dL. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ≥100,000/mm3. Total bilirubin ≤1.5 x ULN. Alanine aminotransferase (ALT) and ...